XML 14 R4.htm IDEA: XBRL DOCUMENT v3.23.1
CONDENSED STATEMENTS OF OPERATIONS - USD ($)
 3 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Operating expenses:    
Research and development $ 1,720,488 $ 965,308
Marketing and advertising 1,115,639 2,204,979
General and administrative 1,059,938 600,665
Total operating expenses 3,896,065 3,770,952
Loss from operations (3,896,065) (3,770,952)
Other income (expense):    
Change in fair value of warrant liability 2,523 (739,306)
Interest income and other, net 34,820 5,599
Total other income (expense), net 37,343 (733,707)
Net loss before taxes (3,858,722) (4,504,659)
Net loss $ (3,858,722) $ (4,504,659)
Basic loss per common share $ (0.40) $ (0.47)
Diluted loss per common share $ (0.40) $ (0.47)
Weighted-average number of basic shares outstanding 9,673,870 9,673,870
Weighted-average number of diluted shares outstanding 9,673,870 9,673,870